GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nanjing Sinolife United Co Ltd (HKSE:03332) » Definitions » YoY EBITDA Growth

Nanjing Sinolife United Co (HKSE:03332) YoY EBITDA Growth : -91.43% (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Nanjing Sinolife United Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Nanjing Sinolife United Co's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was -91.43%.

Nanjing Sinolife United Co's EBITDA per Share for the six months ended in Dec. 2024 was HK$0.00.


Nanjing Sinolife United Co YoY EBITDA Growth Historical Data

The historical data trend for Nanjing Sinolife United Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Sinolife United Co YoY EBITDA Growth Chart

Nanjing Sinolife United Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 85.71 34.62 135.29 1,350.00 -24.14

Nanjing Sinolife United Co Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 79.41 820.00 600.00 33.33 -91.43

Nanjing Sinolife United Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Nanjing Sinolife United Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(0.066-0.087)/ | 0.087 |
=-24.14 %

Nanjing Sinolife United Co's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 )) |
=(0.003-0.035)/ | 0.035 |
=-91.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanjing Sinolife United Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Nanjing Sinolife United Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanjing Sinolife United Co Business Description

Traded in Other Exchanges
N/A
Address
3 Qingma Road, 4/F, Building 3, Qixia District, Jiangsu Province, Nanjing, CHN
Nanjing Sinolife United Co Ltd is a company based in China, primarily engaged in producing and selling nutritional supplements and packaged health food products. The company operates in the People's Republic of China, Australia, and New Zealand. It also sells packaged health food products, cosmetics, and skin care products. The company's product line includes Good Health, Zhongsheng, Hejian, and Cobayer. The company has a business presence in several countries, including the PRC, New Zealand, Australia, Vietnam, and others, but it generates most of its revenue from China. The company has a single business unit that focuses on its products and a sole reportable segment that involves manufacturing and selling nutritional supplements and packaged health food products.
Executives
Genwealth Group Holding Company Limited 2201 Interest of corporation controlled by you
Hin Sang Group (international) Holding Co. Ltd. 2101 Beneficial owner
Gui Pinghu 2101 Beneficial owner
Wu Yanmei 2202 Interest of your spouse
Kwan Lai Man 2201 Interest of corporation controlled by you
Pang Siu Hin 2201 Interest of corporation controlled by you
Gui Ke 2101 Beneficial owner
Li Shi 2202 Interest of your spouse

Nanjing Sinolife United Co Headlines

No Headlines